CVE-2015-3953
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior,...
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- High
- Availability
- High
Exploit likelihood
What each source reports
NVD Score used
9.8
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- Record
CVE-2015-3953- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - CVSS 2.0
- 10.0 High
AV:N/AC:L/Au:N/C:C/I:C/A:C - Weakness
- CWE-259, CWE-798
- Updated
- 2026-11-02
CVE List No score
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- Record
CVE-2015-3953- Weakness
- CWE-259
- Updated
- 2026-11-02
EUVDEUVD-2015-3984 No score
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- Record
EUVD-2015-3984- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-vw52-2pgm-8cj2
9.8
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior,...
Hard-coded accounts may be used to access Hospira Plum A+ Infusion System version 13.4 and prior, Plum A+3 Infusion System version 13.6 and prior, and Symbiq Infusion System, version 3.13 and prior. Hospira recommends that customers close Port 20/FTP and Port 23/TELNET on the affected devices. Hospira has also released the Plum 360 Infusion System which is not vulnerable to this issue.
- Record
GHSA-vw52-2pgm-8cj2- CVSS 3.0
- 9.8 Critical
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H - Weakness
- CWE-798
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2015-3953 is a critical vulnerability (CVSS 9.8) in Hospira Plum A+ Infusion System, published March 25, 2019. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.97%, the 80th percentile. No source names a fixed version.